Signed in · PRO

Guidance history, every release

UnitedHealth Group (UNH) · 8 releases, Jan 16, 2025 to Oct 13, 2026 · rows are metrics, columns are releases

Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing

Metric	Jan 16, 2025 FY24 Q4	Apr 17, 2025 FY25 Q1	Jul 29, 2025 FY25 Q2	Oct 28, 2025 FY25 Q3	Jan 27, 2026 FY25 Q4	Apr 21, 2026 FY26 Q1	Jul 16, 2026 FY26 Q2	Oct 13, 2026 FY26 Q3
For FY2028
Manufacturer drug rebate discount pass-through to clients	—	—	—	—	—	—	New“100%”	—
For FY2027
Doula care coverage eligible members	—	—	—	—	—	—	New“more than 7 million”	—
For FY2026
Eliminations - Revenue	—	—	—	—	New“~($153,500)”	—	—	—
Eliminations Revenues	—	—	—	—	New“~$(5,000)”	—	—	—
Optum - Revenue	—	—	—	—	New“> $257,500”	—	—	—
Optum Eliminations Revenue	—	—	—	—	New“~$(5,000)”	—	—	—
Optum Health (1) Revenues	—	—	—	—	New“> $91,000”	—	—	—
Optum Insight Revenues	—	—	—	—	New“> $21,000”	—	—	—
Optum revenues	—	—	—	—	New“more than $257.5 billion”	—	—	—
Optum Rx Revenues	—	—	—	—	New“> $150,500”	—	—	—
Revenue outlook	—	—	—	—	New“Greater Than $439.0 Billion”	—	—	—
Revenue year-over-year change	—	—	—	—	New“a 2% year-over-year decline”	—	—	—
Total Optum Revenues	—	—	—	—	New“> $257,500”	—	—	—
Total UnitedHealth Group - Revenue	—	—	—	—	New“> $439,000”	—	—	—
Total UnitedHealthcare Revenue	—	—	—	—	New“> $335,000”	—	—	—
UnitedHealthcare Community & State Revenue	—	—	—	—	New“> $95,000”	—	—	—
UnitedHealthcare Employer & Individual Revenue	—	—	—	—	New“> $75,000”	—	—	—
UnitedHealthcare Medicare & Retirement Revenue	—	—	—	—	New“> $165,000”	—	—	—
UnitedHealthcare revenues	—	—	—	—	New“more than $335.0 billion”	—	—	—
Adjusted diluted earnings per share	—	—	—	—	—	New“> $18.25”	—	Raised“At least $20.50”
Adjusted earnings outlook	—	—	—	—	—	New“Greater Than $18.25 Per Share”	Raised“$19.50 to $20.00 Per Share”	—
Adjusted Earnings per Share (1)	—	—	—	—	—	—	New“> $17.75”	—
Adjusted net earnings attributable to UnitedHealth Group common shareholders	—	—	—	—	—	New“> $16,610”	—	Raised“> $18,585”
Adjusted Net Earnings per Share (b)	—	—	—	—	New“> $17.75”	—	Raised“$19.50 - $20.00”	—
Adjusted Operating Earnings - Optum Health	—	—	—	—	New“> $1,577”	—	—	—
Adjusted Operating Earnings - Total Optum	—	—	—	—	New“> $12,577”	—	—	—
Adjusted Operating Earnings Margin - Optum Health	—	—	—	—	New“~1.7%”	—	—	—
Alegeus Technologies acquisition earnings impact	—	—	—	—	—	New“earnings neutral to 2026”	—	—
Diluted earnings per share	—	—	—	—	—	New“> $17.35”	—	Raised“At least $19.50”
Diluted Net Earnings per Share to UNH Shareholders	—	—	—	—	New“> $17.10”	—	Raised“$18.45 - $18.95”	—
Earnings from operations	—	—	—	—	New“Greater Than $24.0 Billion”	—	—	—
Earnings outlook	—	—	—	—	—	New“Greater Than $17.35 Per Share”	—	—
Earnings Outlook (Diluted EPS)	—	—	—	—	—	—	New“$18.45 to $18.95 Per Share”	—
Earnings Outlook (net earnings per share)	—	—	—	—	—	—	—	New“At Least $19.50 Per Share”
Net earnings attributable to UnitedHealth Group common shareholders	—	—	—	—	—	New“> $15,800”	—	Raised“> $17,650”
Net Earnings to UNH Shareholders	—	—	—	—	New“> $15,600”	—	Raised“> $16,750”	—
Net margin	—	—	—	—	New“~3.6%”	—	—	—
Operating Earnings - Optum	—	—	—	—	—	—	New“> $13,200”	—
Operating Earnings - Optum Health	—	—	—	—	—	—	New“> $2,200”	—
Operating Earnings - UnitedHealth Group	—	—	—	—	—	—	New“> $24,000”	—
Operating Earnings - UnitedHealthcare	—	—	—	—	—	—	New“> $10,800”	—
Operating margin	—	—	—	—	New“5.5%”	—	—	—
Optum (a) - Adjusted Operating Earnings	—	—	—	—	—	—	New“> $13,215”	—
Optum (a) - Reported Operating Earnings	—	—	—	—	—	—	New“> $13,450”	—
Optum adjusted operating earnings margin excluding loss contracts impact	—	—	—	—	New“~4.9%”	—	—	—
Optum earnings from operations	—	—	—	—	New“greater than $13.2 billion”	—	—	—
Optum Health - Adjusted Operating Earnings	—	—	—	—	—	—	New“> $2,215”	—
Optum Health - Reported Operating Earnings	—	—	—	—	—	—	New“> $2,275”	—
Optum Health (1) Operating Earnings	—	—	—	—	New“> $2,200”	—	—	—
Optum Health (1) Operating Margin	—	—	—	—	New“~2.4%”	—	—	—
Optum Insight - Adjusted Operating Earnings	—	—	—	—	—	—	New“> $4,750”	—
Optum Insight - Reported Operating Earnings	—	—	—	—	—	—	New“> $4,925”	—
Optum Insight Operating Earnings	—	—	—	—	New“> $4,750”	—	—	—
Optum Insight Operating Margin	—	—	—	—	New“~22.6%”	—	—	—
Optum Rx - Reported Operating Earnings	—	—	—	—	—	—	New“> $6,250”	—
Optum Rx Operating Earnings	—	—	—	—	New“> $6,250”	—	—	—
Optum Rx Operating Margin	—	—	—	—	New“~4.2%”	—	—	—
Return to earnings growth	—	—	New“return to earnings growth”	—	—	—	—	—
Total Optum Operating Earnings	—	—	—	—	New“> $13,200”	—	—	—
Total Optum Operating Margin	—	—	—	—	New“~5.1%”	—	—	—
Total UnitedHealth Group - Operating Earnings	—	—	—	—	New“> $24,000”	—	—	—
UnitedHealth Group - Adjusted Operating Earnings	—	—	—	—	—	—	New“> $25,215”	—
UnitedHealth Group - Reported Operating Earnings	—	—	—	—	—	—	New“> $25,450”	—
UnitedHealthcare - Operating Earnings	—	—	—	—	New“> $10,800”	—	—	—
UnitedHealthcare - Reported Operating Earnings	—	—	—	—	—	—	New“> $12,000”	—
UnitedHealthcare earnings from operations	—	—	—	—	New“greater than $10.8 billion”	—	—	—
UnitedHealthcare Operating Margin	—	—	—	—	New“~3.2%”	—	—	—
Capital Expenditures	—	—	—	—	New“~$3,800”	—	—	—
Cash Flows from Operations	—	—	—	—	New“Greater Than $18.0 Billion”	—	Changed“> $18,000”	—
Commercial Fee - Growth (Contraction) in People Served	—	—	—	—	New“550 – 750”	—	—	—
Commercial Fee - Total People Served	—	—	—	—	New“22,035 – 22,235”	—	—	—
Commercial Risk - Growth (Contraction) in People Served	—	—	—	—	New“(1,400) – (1,300)”	—	—	—
Commercial Risk - Total People Served	—	—	—	—	New“6,765 – 6,865”	—	—	—
Contraction in people served through Medicare Advantage	—	—	—	—	New“(1,400,000) to (1,300,000)”	—	—	—
Depreciation and Amortization	—	—	—	—	New“~$4,400”	—	—	—
Diluted Weighted-Average Shares	—	—	—	—	New“910 – 915”	—	—	—
Dividends Paid (at current rate)	—	—	—	—	New“~$8,000”	—	—	—
Interest Expense	—	—	—	—	New“~$3,700”	—	—	—
Investment and Other Income	—	—	—	—	New“~$3,900”	—	—	—
Medicaid - Growth (Contraction) in People Served	—	—	—	—	New“(715) – (565)”	—	—	—
Medicaid - Total People Served	—	—	—	—	New“6,665 – 6,815”	—	—	—
Medical Care Ratio	—	—	—	—	New“88.8% ± 50 bps”	—	Lowered“88.1% ± 25 bps”	—
Medicare Advantage - Growth (Contraction) in People Served	—	—	—	—	New“(1,200) – (1,150) (1)”	—	—	—
Medicare Advantage - Total People Served	—	—	—	—	New“7,245 – 7,295”	—	—	—
Medicare Advantage medical cost trend acceleration expectation	—	—	New“nearly 10%”	—	—	—	—	—
Medicare Advantage People Served Growth (Contraction)	—	—	—	—	New“(1,200) – (1,150)”	—	—	—
Operating Cost Ratio	—	—	—	—	New“12.8% ± 50 bps”	—	—	—
Optum Health Consumers Served	—	—	—	—	New“~84 million”	—	—	—
Optum Health Fully Accountable Patients	—	—	—	—	New“~4.1 million”	—	—	—
Optum Rx Adjusted Scripts	—	—	—	—	New“> 1.52 billion”	—	—	—
Pediatric prior approval requirement elimination	—	—	—	—	—	—	New“nearly two-thirds”	—
Prior approval volume elimination	—	—	—	—	—	—	New“30%”	—
Projected 2026 expected reduction of loss contracts reserves	—	—	—	—	—	New“$402 million”	—	—
Share repurchase	—	—	—	—	—	New“at least $2 billion”	—	—
Share Repurchase	—	—	—	—	New“~$2,500”	—	Changed“at least $5.0 billion”	—
Stand-Alone Part D Prescription Drug Plans - Growth (Contraction) in People Served	—	—	—	—	New“(200) – (100)”	—	—	—
Stand-Alone Part D Prescription Drug Plans - Total People Served	—	—	—	—	New“2,570 – 2,670”	—	—	—
Standardized Medicare Supplement - Growth (Contraction) in People Served	—	—	—	—	New“(50) – 0”	—	—	—
Standardized Medicare Supplement - Total People Served	—	—	—	—	New“4,235 – 4,285”	—	—	—
Stock repurchase	—	—	—	—	—	New“at least $2.0 billion”	—	—
Tax Rate	—	—	—	—	New“~19.25%”	—	Reiterated“~19.25%”	—
Total Commercial - Growth (Contraction) in People Served	—	—	—	—	New“(850) – (550)”	—	—	—
Total Commercial - Total People Served	—	—	—	—	New“28,800 – 29,100”	—	—	—
Total Medical - Growth (Contraction) in People Served	—	—	—	—	New“(2,815) – (2,265)”	—	—	—
Total Medical - Total People Served	—	—	—	—	New“46,945 – 47,495”	—	—	—
UnitedHealthcare membership	—	—	—	—	New“range between 46.9 million to 47.5 million”	—	—	—
UnitedHealthcare prior approvals included in electronic submission standardization	—	—	—	—	—	—	New“more than 70%”	—
For FY2025
Community & State Revenues	—	—	New“$94,200 - $94,700”	—	—	—	—	—
Eliminations - Revenue	—	—	New“($164,500) - ($165,000)”	—	—	—	—	—
Employer & Individual Revenues	—	—	New“$79,600 - $80,100”	—	—	—	—	—
Medicare & Retirement Revenues	—	—	New“$170,200 - $170,700”	—	—	—	—	—
Optum Eliminations Revenues	—	—	New“($5,100)”	—	—	—	—	—
Optum Health revenues	—	—	New“$101.1 billion to $101.6 billion”	—	—	—	—	—
Optum Insight contract revenue backlog	—	—	New“$32.0 billion”	—	—	—	—	—
Optum Insight revenues	—	—	New“$19.0 billion to $19.5 billion”	—	—	—	—	—
Optum Rx revenues	—	—	New“$151.0 billion to $151.5 billion”	—	—	—	—	—
Revenue Outlook	—	—	New“$445.5 Billion to $448.0 Billion”	—	—	—	—	—
Revenues	New“$450 billion to $455 billion”	—	—	—	—	—	—	—
Revenues - Eliminations	—	—	New“(164,500) - (165,000)”	—	—	—	—	—
Revenues - UnitedHealthcare	—	—	New“344,000 - 345,500”	—	—	—	—	—
Total consolidated revenue	—	—	New“$445,500 - $448,000”	—	—	—	—	—
Total Optum Revenues	—	—	New“$266,000 - $267,500”	—	—	—	—	—
Total UnitedHealth Group - Revenue	—	—	New“$445,500 - $448,000”	—	—	—	—	—
Total UnitedHealthcare Revenue	—	—	New“$344,000 - $345,500”	—	—	—	—	—
UnitedHealthcare revenues	—	—	New“$344.0 billion to $345.5 billion”	—	—	—	—	—
Adjusted diluted earnings per share	New“$29.50 - $30.00”	—	—	Lowered“At least $16.25”	—	—	—	—
Adjusted earnings outlook	—	New“$26 to $26.50 Per Share”	—	—	—	—	—	—
Adjusted Earnings Outlook	—	—	—	New“Adjusted Earnings of at least $16.25 Per Share”	—	—	—	—
Adjusted net earnings	—	—	—	New“at least $16.25 per share”	—	—	—	—
Adjusted net earnings attributable to UnitedHealth Group common shareholders	New“$27,075 - $27,675”	—	—	Lowered“At least $14,825”	—	—	—	—
Adjusted Net Earnings per Share (a)	—	—	New“At least $16.00”	—	—	—	—	—
Diluted earnings per share	New“$28.15 - $28.65”	—	—	Lowered“At least $14.90”	—	—	—	—
Diluted Net Earnings per Share	—	—	New“At least $14.65”	—	—	—	—	—
Earnings from operations - Optum	—	—	New“$12,550 - $12,850”	—	—	—	—	—
Earnings from operations - UnitedHealthcare	—	—	New“9,000 - 9,300”	—	—	—	—	—
Earnings Outlook	—	—	—	New“at least $14.90 Per Share”	—	—	—	—
Earnings Outlook (Diluted EPS)	—	—	New“at least $14.65 Per Share”	—	—	—	—	—
Net earnings	—	—	—	New“at least $14.90 per share”	—	—	—	—
Net earnings attributable to UnitedHealth Group common shareholders	New“$25,850 - $26,450”	—	Lowered“At least $13,350”	Raised“At least $13,600”	—	—	—	—
Net earnings outlook	—	New“$24.65 to $25.15 Per Share”	—	—	—	—	—	—
Operating margin	—	—	New“4.8% - 5.0%”	—	—	—	—	—
Optum Health earnings from operations	—	—	New“$3.0 billion to $3.1 billion”	—	—	—	—	—
Optum Health Operating Earnings	—	—	New“$3,000 - $3,100”	—	—	—	—	—
Optum Health operating earnings margin	—	—	New“3.0% to 3.1%”	—	—	—	—	—
Optum Insight earnings from operations	—	—	New“$3.55 billion to $3.65 billion”	—	—	—	—	—
Optum Insight Operating Earnings	—	—	New“$3,550 - $3,650”	—	—	—	—	—
Optum Insight operating earnings margin	—	—	New“18.2% to 19.2%”	—	—	—	—	—
Optum Rx earnings from operations	—	—	New“$6.0 billion to $6.1 billion”	—	—	—	—	—
Optum Rx Operating Earnings	—	—	New“$6,000 - $6,100”	—	—	—	—	—
Optum Rx operating margin	—	—	New“4.0%”	—	—	—	—	—
Total Optum Operating Earnings	—	—	New“$12,550 - $12,850”	—	—	—	—	—
Total Optum Operating Margin	—	—	New“4.7% - 4.8%”	—	—	—	—	—
Total UnitedHealth Group - Operating Earnings	—	—	New“$21,550 - $22,150”	—	—	—	—	—
UnitedHealthcare - Operating Earnings	—	—	New“$9,000 - $9,300”	—	—	—	—	—
UnitedHealthcare earnings from operations	—	—	New“$9.0 billion to $9.3 billion”	—	—	—	—	—
UnitedHealthcare Operating Margin	—	—	New“2.6% - 2.7%”	—	—	—	—	—
Cash flow from operations	New“$32 billion to $33 billion”	—	—	—	—	—	—	—
Cash flows from operations	—	—	New“~$16,000”	—	—	—	—	—
Commercial Fee - Growth in People Served	—	—	New“720”	—	—	—	—	—
Commercial Fee - Total People Served	—	—	New“21,605”	—	—	—	—	—
Commercial Risk - Growth in People Served	—	—	New“(385)”	—	—	—	—	—
Commercial Risk - Total People Served	—	—	New“8,460”	—	—	—	—	—
Contraction in individual insured offerings	—	—	New“180,000”	—	—	—	—	—
Decline in employer-sponsored group products	—	—	New“205,000”	—	—	—	—	—
Depreciation and amortization	—	—	New“~$4,300”	—	—	—	—	—
Diluted weighted-average shares outstanding	—	—	New“912 - 914”	—	—	—	—	—
Growth in people served by offerings for seniors and people with complex needs	—	New“up to 800,000”	—	—	—	—	—	—
Growth within self-funded employer-sponsored offerings	—	—	New“720,000”	—	—	—	—	—
Interest expense	—	—	New“~$4,200”	—	—	—	—	—
Investment and other income	—	—	New“~$4,400”	—	—	—	—	—
Medicaid - Growth in People Served	—	—	New“200”	—	—	—	—	—
Medicaid - Total People Served	—	—	New“7,635”	—	—	—	—	—
Medical cost ratio	—	—	New“89.25% +/- 25 basis points”	—	—	—	—	—
Medical cost trend in Medicare Advantage offerings	—	—	New“~7.5%”	—	—	—	—	—
Medicare Advantage - Growth in People Served	—	—	New“650”	—	—	—	—	—
Medicare Advantage - Total People Served	—	—	New“8,495”	—	—	—	—	—
Operating cost ratio	—	—	New“12.75% +/- 25 basis points”	—	—	—	—	—
Optum Health Fully Accountable Value-Based Care Patients	—	—	New“5 million”	—	—	—	—	—
Optum Health new value-based care patients	—	New“650,000”	—	—	—	—	—	—
Optum Health patients served under fully accountable value-based care models, expected increase	—	—	New“~300,000 to 5 million”	—	—	—	—	—
Optum Health value-based care patients served growth	New“an additional 650,000 patients”	—	—	—	—	—	—	—
Optum Rx adjusted scripts	—	—	New“1.67 billion”	—	—	—	—	—
People served with commercial benefits, expected increase	—	—	New“up to 335,000”	—	—	—	—	—
People served with commercial insured offerings, expected decline	—	—	New“385,000”	—	—	—	—	—
People served with medical benefits, expected increase	—	—	New“up to 1.135 million”	—	—	—	—	—
Pricing expectation for Medicare Advantage	—	—	New“just over 5%”	—	—	—	—	—
Stand-Alone Part D Prescription Drug Plans - Growth in People Served	—	—	New“(300)”	—	—	—	—	—
Stand-Alone Part D Prescription Drug Plans - Total People Served	—	—	New“2,750”	—	—	—	—	—
Standardized Medicare Supplement - Growth in People Served	—	—	New“(50)”	—	—	—	—	—
Standardized Medicare Supplement - Total People Served	—	—	New“4,285”	—	—	—	—	—
Tax rate	—	—	New“~18.5%”	—	—	—	—	—
Total Commercial - Growth in People Served	—	—	New“335”	—	—	—	—	—
Total Commercial - Total People Served	—	—	New“30,065”	—	—	—	—	—
Total Medical - Growth in People Served	—	—	New“1,135”	—	—	—	—	—
Total Medical - Total People Served	—	—	New“50,480”	—	—	—	—	—
No period stated
Long-term earnings growth rate target	—	New“13 to 16%”	—	—	—	—	—	—
Long-term debt-to-capital ratio target	—	—	—	—	New“40.0%”	Reiterated“approximately 40.0%”	Reiterated“approximately 40.0%”	Reiterated“approximately 40.0%”
Quarterly dividend rate	—	—	New“$2.21”	—	—	—	—	—
Timing to reach long-term debt-to-capital ratio target	—	—	—	—	—	New“expects to reach that level in the back half of 2026”	—	—

Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.